cbdMD Inc (YCBD) - Total Assets
Based on the latest financial reports, cbdMD Inc (YCBD) holds total assets worth $9.90 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cbdMD Inc (YCBD) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
cbdMD Inc - Total Assets Trend (2015–2024)
This chart illustrates how cbdMD Inc's total assets have evolved over time, based on quarterly financial data. See shareholders equity of cbdMD Inc for net asset value and shareholders' equity analysis.
cbdMD Inc - Asset Composition Analysis
Current Asset Composition (September 2024)
cbdMD Inc's total assets of $9.90 Million consist of 60.4% current assets and 39.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.2% |
| Accounts Receivable | $983.91K | 9.3% |
| Inventory | $2.37 Million | 22.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.89 Million | 27.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how cbdMD Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see YCBD company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: cbdMD Inc's current assets represent 60.4% of total assets in 2024, a decrease from 67.9% in 2015.
- Cash Position: Cash and equivalents constituted 23.2% of total assets in 2024, down from 30.0% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 26.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 27.3% of total assets.
cbdMD Inc Competitors by Total Assets
Key competitors of cbdMD Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Alkem Laboratories Limited
NSE:ALKEM
|
India | Rs202.87 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Alkermes plc
F:8AK
|
Germany | €4.26 Billion |
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
|
China | CN¥35.27 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
|
China | CN¥6.49 Billion |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
|
China | CN¥1.41 Billion |
cbdMD Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 0.93 | 3.08 |
| Quick Ratio | 0.78 | 0.52 | 2.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.01 Million | $-567.61K | $16.02 Million |
cbdMD Inc - Advanced Valuation Insights
This section examines the relationship between cbdMD Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.69 |
| Latest Market Cap to Assets Ratio | 0.62 |
| Asset Growth Rate (YoY) | -34.7% |
| Total Assets | $10.58 Million |
| Market Capitalization | $6.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values cbdMD Inc's assets below their book value (0.62x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: cbdMD Inc's assets decreased by 34.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for cbdMD Inc (2015–2024)
The table below shows the annual total assets of cbdMD Inc from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | $10.58 Million | -34.66% |
| 2023-09-30 | $16.20 Million | -60.30% |
| 2022-09-30 | $40.79 Million | -67.34% |
| 2021-09-30 | $124.88 Million | +12.67% |
| 2020-09-30 | $110.84 Million | +17.27% |
| 2019-09-30 | $94.52 Million | +529.38% |
| 2018-09-30 | $15.02 Million | +112.43% |
| 2017-09-30 | $7.07 Million | +335.48% |
| 2016-09-30 | $1.62 Million | -10.94% |
| 2015-09-30 | $1.82 Million | -- |
About cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more